Qiagen NV (QGEN)
41.52
-0.37
(-0.88%)
USD |
NYSE |
Apr 24, 16:00
41.53
+0.01
(+0.02%)
Pre-Market: 20:00
Qiagen Total Assets (Quarterly): 6.115B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.115B |
| September 30, 2023 | 5.907B |
| June 30, 2023 | 6.347B |
| March 31, 2023 | 6.279B |
| December 31, 2022 | 6.288B |
| September 30, 2022 | 6.517B |
| June 30, 2022 | 6.154B |
| March 31, 2022 | 6.184B |
| December 31, 2021 | 6.147B |
| September 30, 2021 | 6.043B |
| June 30, 2021 | 5.907B |
| March 31, 2021 | 5.763B |
| December 31, 2020 | 5.870B |
| September 30, 2020 | 5.771B |
| June 30, 2020 | 5.295B |
| March 31, 2020 | 5.181B |
| December 31, 2019 | 5.236B |
| September 30, 2019 | 5.143B |
| June 30, 2019 | 5.383B |
| March 31, 2019 | 5.420B |
| December 31, 2018 | 5.748B |
| September 30, 2018 | 5.299B |
| June 30, 2018 | 5.309B |
| March 31, 2018 | 5.105B |
| December 31, 2017 | 5.039B |
| Date | Value |
|---|---|
| September 30, 2017 | 5.097B |
| June 30, 2017 | 4.556B |
| March 31, 2017 | 4.068B |
| December 31, 2016 | 4.308B |
| September 30, 2016 | 4.328B |
| June 30, 2016 | 4.119B |
| March 31, 2016 | 4.120B |
| December 31, 2015 | 4.179B |
| September 30, 2015 | 4.159B |
| June 30, 2015 | 4.131B |
| March 31, 2015 | 4.170B |
| December 31, 2014 | 4.454B |
| September 30, 2014 | 4.461B |
| June 30, 2014 | 4.564B |
| March 31, 2014 | 4.487B |
| December 31, 2013 | 4.088B |
| September 30, 2013 | 4.055B |
| June 30, 2013 | 3.976B |
| March 31, 2013 | 4.034B |
| December 31, 2012 | 4.088B |
| September 30, 2012 | 3.956B |
| June 30, 2012 | 3.877B |
| March 31, 2012 | 3.798B |
| December 31, 2011 | 3.730B |
| September 30, 2011 | 3.948B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.143B
Minimum
Sep 2019
6.517B
Maximum
Sep 2022
5.870B
Average
5.907B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| MoonLake Immunotherapeutics | 526.54M |
| LENZ Therapeutics Inc | -- |
| Thermo Fisher Scientific Inc | 98.73B |
| uniQure NV | 831.69M |
| ProQR Therapeutics NV | 152.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.307B |
| Shareholders Equity (Quarterly) | 3.808B |
| Debt to Equity Ratio | 0.3965 |
| Current Ratio | 1.990 |
| Net Debt Paydown Yield | 1.57% |